Evocalcet |
MT-4580; KHK-7580 |
Approved |
Mitsubishi Tanabe Pharma Corp |
Orkedia |
Japan |
Hyperparathyroidism, Secondary |
Kyowa Hakko Kirin |
2018-03-23 |
Hyperparathyroidism, Secondary; Parathyroid Neoplasms; Hyperparathyroidism, Primary; Hyperparathyroidism |
Details
|
Parathyroid hormone (Shire) |
423562; ALX-111; SHP-634; SHP-635; NPSP-558; NPSP-795; PTH 1-84; SB-423562; PTH (1-84); rhPTH-1-84; rhPTH (1-84) |
Approved |
Shire |
Natpar, Natpara, Preotact |
EU |
Hypoparathyroidism |
Shire Pharmaceuticals Ireland Ltd |
2006-04-24 |
Osteoporosis; Osteoporosis, Postmenopausal; Hypoparathyroidism |
Details
|
Etelcalcetide Hydrochloride |
AMG-416; KAI-4169; KAI-4169-HCl; ONO-5163 |
Approved |
Amgen Inc |
Parsabiv |
United States |
Hyperparathyroidism, Secondary |
Kai Pharmaceuticals |
2016-11-11 |
Hyperparathyroidism, Secondary; Edema, Cardiac; Renal Insufficiency, Chronic |
Details
|
Upacicalcet |
SK-1403; AJT-240 |
Approved |
Ea Pharma |
ウパシタ, Upasita |
Japan |
Hyperparathyroidism, Secondary |
Sanwa Kagaku Kenkyusho |
2021-06-23 |
Hyperparathyroidism, Secondary; Hyperparathyroidism |
Details
|
Cinacalcet Hydrochloride |
AMG-073; KRN-1493; NPS-1493; AMG-073.HCl |
Approved |
Amgen Inc |
盖平, Mimpara, Parareg, Regpara, Sensipar, Sensipar/Mimpara |
Mainland China |
Hypercalcemia; Hyperparathyroidism; Hyperparathyroidism, Secondary |
Kyowa Hakko Kirin |
2004-03-08 |
Hyperparathyroidism, Secondary; Rejection of renal transplantation; Parathyroid Neoplasms; Hypophosphatemia; Nephrosis; Edema, Cardiac; Kidney Diseases; Hypercalcemia; Hyperparathyroidism, Primary; Renal Insufficiency, Chronic; Kidney Failure, Chronic; Hyperparathyroidism; Chronic Kidney Disease-Mineral and Bone Disorder |
Details
|
Strontium Ranelate |
FK-481; S-12911; S-12911-2 |
Approved |
Servier |
欧思美, Osseor, Protos, Protelos |
Mainland China |
Osteoporosis, Postmenopausal |
Les Laboratoires Servier |
2004-09-20 |
Osteoporosis, Postmenopausal |
Details
|